SeQuent Scientific announces acquisition of Bremer Pharma in Germany

Mumbai, April 21,20 18: Sequent Scientific announced that its wholly owned subsidiary Alivira Animal Health through Alivira Ireland, has on 17 April 2018 signed an agreement with simultaneous closing to acquire 100% of Bremer Pharma, Zydus Cadila’s Animal Health Business in Germany.

Bremer Pharma, founded in 1982 is a niche veterinary health company in Germany with focus on cattle and swine segments. Bremer has a portfolio of over 400+ registered products across Europe, Far East, MENA, Russia & Africa operating in vitamins, antibiotics and hormones.

Bremer comes with a EUGMP compliant injectable manufacturing facility with approval from German Competent Authority LANUV. The site was recently reinspected and obtained a renewed GMP certificate on 12 March 2018.

This acquisition provides Alivira’s with a beta-lactam & non-beta lactam injectables facility for EU markets, which compliments its Orals & Powders beta-lactam and non-beta lactam facility based at Barcelona in Spain. EU is Alivira’s largest market accounting to 60 percent of revenues.

Commenting on the acquisition,Manish Gupta, Managing Director said ‘We are excited with the addition of Bremer Pharma to the Alivira fold as it consolidates our position as a leading Animal Health Company in the European market”.

”This also provides comprehensive manufacturing footprint in EU across Injectables,Orals, Solids, and Powder range and front – end presence in Top 6 of 10 EU markets. The scale up and growth momentum will further drive the next phase of value creation through accelerated revenues and margin expansion in the business”.Mr Gupta added.

United News of India